Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial

Zhi Li, Daming Yuan, Yu Yu, Jie Xu, Weili Yang, Li Chen, Nanbo Luo

Open source

DOI
10.1186/s13063-024-07934-z
Published
2024-01-27
Container
Trials
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-024-07934-z,
  title = {Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial},
  author = {Zhi Li and Daming Yuan and Yu Yu and Jie Xu and Weili Yang and Li Chen and Nanbo Luo},
  year = {2024},
  journal = {Trials},
  doi = {10.1186/s13063-024-07934-z},
  url = {https://doi.org/10.1186/s13063-024-07934-z}
}

RIS

TY  - JOUR
TI  - Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial
AU  - Zhi Li
AU  - Daming Yuan
AU  - Yu Yu
AU  - Jie Xu
AU  - Weili Yang
AU  - Li Chen
AU  - Nanbo Luo
PY  - 2024
JO  - Trials
DO  - 10.1186/s13063-024-07934-z
UR  - https://doi.org/10.1186/s13063-024-07934-z
ER  - 

APA

Li, Z., Yuan, D., Yu, Y., Xu, J., Yang, W., Chen, L., & Luo, N. (2024). Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial. Trials. https://doi.org/10.1186/s13063-024-07934-z

Source records